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Summary
We investigated a Swedish family with nonsyndromic
progressive bilateral sensorineural hearing loss. Thirteen
candidate loci for autosomal dominant nonsyndromic
hearing loss were tested for linkage in this family. We
found significant LOD scores (13) for markers at can-
didate locus DFNA12 (11q22-q24) and suggestive LOD
scores (12) for markers at locus DFNA2 (1p32). Our
results for markers on chromosome 11 narrowed down
the candidate region for the DFNA12 locus. A detailed
analysis of the phenotypes and haplotypes shared by the
affected individuals supported the notion that two genes
segregated together with hearing impairment in the fam-
ily. Severely affected family members had haplotypes
linked to the disease allele on both chromosomes 1 and
11, whereas individuals with milder hearing loss had
haplotypes linked to the disease allele on either chro-
mosome 1 or chromosome 11. These observations sug-
gest an additive effect of two genes, each gene resulting
in a mild and sometimes undiagnosed phenotype, but
both together resulting in a more severe phenotype.
Introduction
Hearing loss is one of the most frequent sensory dis-
orders in humans (Petit 1996) and may result in an al-
teration of language, speech, cognition, and psychosocial
development. Genetic as well as environmental factors
are implicated in the etiology of the illness. On the basis
of age at onset, hearing deterioration is classified as a
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prelingual (congenital or developing in early childhood)
or postlingual type (age at onset is after speech has de-
veloped). The incidence of prelingual deafness is 1/1,000
newborns. The prevalence of postlingual hearing loss
increases with age: it affects 1% of young adults, 10%
of persons by age 60 years, and 50% of persons at age
x75 years (Morton 1991). It has been postulated that
postlingual nonsyndromic hearing loss (NSHL) more
frequently segregates as an autosomal dominant trait
(Gorlin 1995; Van Camp et al. 1997b).
Genetic studies of NSHL are hampered by a high de-
gree of genetic heterogeneity, multiple phenocopies, and
assortative marriages between deaf persons. To date, 15
autosomal dominant, 19 autosomal recessive, 5 X-
linked, and 2 mitochondrial loci have been reported for
NSHL (see the Hereditary Hearing Loss home page).
Moreover, five nuclear genes (de Kok et al. 1995; Kelsell
et al. 1997; Liu et al. 1997a, 1997b; Lynch et al. 1997;
Vahava et al. 1998) implicated in NSHL have been iden-
tified, and mutations in three more genes have been as-
sociated with hearing loss (Hollway et al. 1998; Li et
al. 1998; Verhoeven et al. 1998).
We performed a linkage analysis of an extended Swed-
ish pedigree that segregates, in an autosomal dominant
mode, for postlingual progressive deafness. The family
initially was tested for linkage to loci previously reported
to be candidates for autosomal dominant forms of
NSHL. Markers selected for two loci, DFNA2 (MIM
600101) on chromosome 1p and DFNA12 (MIM
601842) on chromosome 11q, provided strong indica-
tions for linkage, suggesting that both genes contribute
to the etiology of hearing impairment in this Swedish
family.
Methods
Clinical Diagnosis
The family was ascertained at O¨rebro Regional Hos-
pital, O¨rebro, Sweden. Otoscopic and audiometric ex-
aminations were performed on all cooperative family
members. Pure-tone audiometry was performed with air
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conduction at 125, 250, 500, 1,000, 1,500, 2,000,
3,000, 4,000, 6,000, and 8,000 Hz and with bone con-
duction at 250, 500, 1,000, 1,500, 2,000, 3,000, and
4,000 Hz. In total, audiograms were available for 27
members of the family. For a few family members, au-
diograms were available for different ages. Thus, we
were able to follow the progression of the hearing im-
pairment. A detailed description of audiometric features
is in progress (E. Borg, unpublished data). All individuals
included in this study gave informed consent for the use
of their clinical data for research purposes.
DNA Analysis
Genomic DNA was prepared from peripheral blood
lymphocytes, by phenol-chloroform extraction (Lind-
qvist et al. 1996). Microsatellite polymorphisms were
amplified by PCR. Most of the microsatellite markers
were analyzed by use of a multiplex fluorescent-detec-
tion method, described elsewhere (Lindqvist et al. 1996),
with fluorescently labeled markers ordered from Genset
or Research Genetics. PCR reactions had a total volume
of 10 ml containing 50 ng DNA, 2.5 pmol each primer,
12.5 mM each dNTP, and 0.5 U AmpliTaq polymerase
(Perkin Elmer). After an initial step of 95C for 5 min,
PCR conditions were as follows: 10 cycles of denatur-
ation at 94C for 30 s, annealing at 47C–62C for 1
min, and elongation at 72C for 1 min; 20 cycles of 89C
for 30 s, 47C–62C for 1 min, and 72C for 1 min; and
a final extension step at 72C for 10 min. Amplification
reactions were performed in a PTC-225 thermocycler
(MJ Research). Fluorescent PCR products were resolved
on 4% polyacrylamide gels and were detected by use of
an ABI 377 DNA Sequencer (Applied Biosystems). Sizes
of marker alleles were defined by use of GENESCAN
software, version 2.0.1 (Applied Biosystems). Analyzed
data were imported to the GENOTYPER software pack-
age, version 1.1 (Applied Biosystems), for an allele-call-
ing procedure and to make a final table of genotypes.
Overall, we genotyped 52 microsatellite markers. In-
itially, one marker per candidate locus was tested. The
two candidate regions DFNA2 (1p32) and DFNA12
(11q22-24), for which linkage was detected, were tested
more thoroughly by typing 25 and 16 microsatellite
markers, respectively. All microsatellite markers used are
listed in the Ge´ne´thon map (Dib et al. 1996) and/or the
Genetic Location Database (LDB) (Collins et al. 1996).
In some cases, the order of the markers on DFNA2 and
DFNA12 differed in the different maps.
Simulation Analysis
Simulation analysis was performed by use of the
SLINK option of the LINKAGE software package (Cot-
tingham et al. 1993; Schaffer et al. 1994), to determine
the probability of detection of linkage in our family. The
same genetic models and phenotype definition described
in the Linkage Analysis and Results sections, respec-
tively, were used for this analysis. Genotypes were sim-
ulated, for 500 replicates, for a marker with five alleles
of equal frequencies. The marker was assumed to lie at
a recombination distance of .0 (linked) or .5 (unlinked)
from the disease gene. Simulation analysis was per-
formed for two models, with age at onset set to 20 years
for one and 30 years for the other. When the age at onset
of the disease was assumed to be 20 years, a maximum
LOD score of 3.8 and an average LOD score of 2.74
were obtained. The probability that a LOD score 13
would be obtained by chance was . For the8! 1# 10
model with a disease age at onset of 30 years, the max-
imum LOD score was 2.69, and the average LOD score
was 1.89. The probability that a LOD score 12.5 would
be obtained by chance was .002.
Linkage Analysis
Pairwise linkage analysis was performed by use of the
MLINK option of the LINKAGE software package
(FASTLINK 3.0P) (Cottingham et al. 1993; Schaffer et
al. 1994). Multipoint linkage analysis was performed by
use of the LINKMAP option of the same software
package.
Affection status was defined as described in Results.
Hearing loss in this family was considered to be an au-
tosomal dominant trait with a maximum penetrance of
98% and a disease-allele frequency of 0.1%. For the
analysis of candidate loci previously reported to be
linked to autosomal dominant NSHL, we used the same
age at onset used in the original studies, except for loci
linked to congenital hearing loss, for which the age at
onset was set to 20 years. The haplotypes were assigned
manually.
Results
Two Different Affected Phenotypes Segregate in a
Swedish Pedigree
The pathophysiological analysis of affected family
members (E. Borg, unpublished data) showed outer hair-
cell damage, without signs of brain-stem and eighth-
nerve involvement. According to age at onset and degree
of impairment, the affected family members were clas-
sified into two phenotypic classes (I and II; fig. 1). The
two phenotypes differ in age at onset, progression, and
degree of hearing impairment. Phenotype I comprised a
group of nine patients (fig. 2) with severe hearing loss,
with a mean age at onset of years. The audi-9 2.2
ograms of these patients showed decreased hearing, par-
ticularly at high frequencies (6–8 kHz), with a X80 dB
drop at age 50 years. These patients usually did not show
hearing impairment at frequencies !500 Hz. Phenotype
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Figure 1 Schematic representation of audiograms for three phenotypic classes: one unaffected phenotype and two affected phenotypes (I
and II). Each plot represents audiometric data for the left ear of three random persons belonging to each specific phenotypic class. Individuals
from each class were divided into two age groups: !20 years of age (top row) and x20 years of age (bottom row). The two phenotypic classes
differ in age at onset, progression (compare top and bottom plots for each class), and severity of the hearing impairment.
II was observed in four persons (fig. 2) with mild hearing
loss at only high frequencies (4–6 kHz), with a mean
age at onset of years. At high frequencies (4–819 5.5
kHz), the patients with phenotype I had a mean level of
hearing impairment of dB, at mean age54.6 20
years, whereas those with phenotype II had12.3 3.6
a mean level of hearing loss of dB, at mean24.2 9.5
age years (data for the hearing impairment19.75 5
was calculated for the left ear). All individuals with phe-
notype I and two individuals (III:9 and III:14) with phe-
notype II lacked a history of exposure to environmental
factors that could explain their hearing disability. Two
individuals (III:7 and III:10) with phenotype II had a
history of head trauma or potential ototoxic antibiotics.
For linkage analysis, only individuals with phenotype I
were considered to be affected, whereas individuals with
phenotype II were specified as “unknown.” Individual
III:1 was specified as “unknown,” because he did not
fulfill completely the criteria for phenotype I and because
his in-married father suffered from a mild hearing im-
pairment. Individuals with normal hearing were consid-
ered to be unaffected if they were older than the selected
age at onset, whereas younger individuals were specified
as “unknown.”
Linkage-Analysis Results
We obtained negative LOD scores for 11 of 13 can-
didate loci tested. However, markers positioned around
the two candidate loci DFNA2 (1p32) and DFNA12
(11q22-24) gave indications for linkage. Results for
these markers are shown in table 1. For markers
D11S4171 and D11S4094 on chromosome 11, we ob-
tained maximum LOD scores of 3.87 and 3.79, respec-
tively. For chromosome 1, analysis with markers
D1S472 and D1S186 resulted in a maximum LOD score
of 2.69 for both markers.
Multipoint analysis of chromosome 11 markers re-
vealed a peak LOD score of 3.86, which was obtained
at a map position corresponding to D11S4171 on chro-
mosome 11. For markers on chromosome 1, the mul-
tipoint analysis resulted in a peak LOD score of 2.69 at
0.1 cM centromeric to marker D1S2723 and at 0.5 cM
telomeric to marker D1S255 (data not shown).
Haplotype Analysis
The most-likely haplotypes for all available family
members were constructed (fig. 2). Fine mapping of
chromosome 11 revealed two key recombinants (indi-
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Figure 2 Most-likely haplotypes. The definitions of the symbols are indicated in the upper-left corner of the figure. The numbers between
the bars correspond to the markers shown in the upper-right corner of the figure. Blackened and hatched bars represent haplotypes segregating
with the disease allele, and unblackened bars represent haplotypes segregating with a healthy allele. A vertical line indicates a region that was
not informative. Dotted, gray bars represent haplotypes from in-married individuals. The left haplotypes are from fathers, and the right haplotypes
are from mothers. Below the individual designations we have indicated current age/age at onset. A question mark (?) indicates that the age at
onset was not known. All individuals that belong to the family are shown in the figure. The order of the markers is according to the LDB, in
which MYCL1 is placed telomeric to D1S432.
viduals III:6 and III:2) that narrowed the previously re-
ported region of the DFNA12 locus, from 36 cM to 12
cM interval between markers D11S4104 and D11S934.
In affected individual III:6, a recombination event had
occurred between markers D11S4104 and D11S4171,
which positions the disease allele telomeric to marker
D11S4104. In addition, in healthy individual III:2, a
recombination event had occurred between markers
D11S934 and D11S4094, which localizes the disease
gene centromeric to marker D11S934. On chromosome
1, a crossover event between markers D1S2729 and
D1S2723 in patient III:6 positions a possible disease-
allele region centromeric to marker D1S2729, while a
recombination event between markers D1S186 and
MYCL1 in patient II:11 excludes the region centromeric
to marker MYCL1. The genetic distance between mark-
ers MYCL1 and D1S2729 is ∼6 cM (Collins et al. 1996).
All individuals with severe hearing impairment (phe-
notype I) share haplotypes linked to the disease allele
on both chromosomes (11q22-24 and 1p32). Individuals
showing a milder hearing loss (phenotype II) carry only
one of the disease haplotypes, on chromosome 1 or chro-
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Table 1
Results of Two-Point Linkage Analysis
LOCUS AND
MARKER
LOD SCORE, AT RECOMBINATION FRACTION OF
.00 .01 .05 .1 .2
DFNA12:
D11S4104 2.29 .31 .30 .49 .55
D11S4171 3.87 3.81 3.56 3.23 2.52
D11S925 2.62 2.62 2.57 2.43 1.98
D11S4107 2.47 2.46 2.38 2.22 1.79
D11S4094 3.79 3.73 3.48 3.16 2.46
D11S934 .90 1.09 1.43 1.54 1.40
D11S912 .98 1.15 1.47 1.56 1.41
D11S4198 8.67 2.55 .88 .2 .29
DFNA2:
D1S201 1.92 1.24 .08 .33 .52
D1S2729 1.21 .66 1.19 1.28 1.13
D1S472 2.69 2.65 2.47 2.24 1.73
D1S255 2.12 2.08 1.94 1.75 1.34
D1S186 2.69 2.65 2.47 2.24 1.73
MYCL1 1.31 .66 1.19 1.28 1.12
D1S432 1.91 .06 .63 .77 .72
D1S193 1.91 .06 .63 .77 .72
mosome 11. Healthy persons who were older than the
selected age at onset did not have either of the two hap-
lotypes that segregate with the disease.
Discussion
We studied an extended Swedish family with pro-
gressive bilateral sensorineural NSHL, and our results
indicate linkage of markers at two candidate loci,
DFNA2 (1p32) and DFNA12 (11q22-24). The hearing
phenotype in the family is progressive, and the age at
onset varied within the range ∼7–30 years. Thus, to test
candidate loci for linkage to progressive hearing loss
(e.g., DFNA2), we used the age at onset proposed in the
original studies. To test loci linked to congenital hearing
loss (e.g., DFNA12), we set the age at onset to 20 years,
since the age at onset for the hearing defects is clearly
postlingual in the Swedish family.
Maximum LOD scores of 3.8 and 2.67 were obtained
for markers at DFNA12 and DFNA2, respectively. As
was suggested by simulation data from two models, for
which age at onset was set to 20 years for one and 30
years for the other, these LOD scores correspond to the
maximum expected (see Methods).
The possibility of having two loci involved in hearing
deterioration in the Swedish family was unexpected,
since the disease segregates as an apparent monogenic
autosomal dominant trait. However, it has been pos-
tulated that, under certain circumstances, digenically in-
herited phenotypes may resemble monogenic autosomal
dominant traits (Johnson 1980). The hypothesis of di-
genic inheritance in the Swedish pedigree is supported
by a detailed analysis of the haplotypes and the asso-
ciated phenotypes of all the family members. We noticed
that the subjects with the severe phenotype I have in-
herited haplotypes linked to the disease allele on both
chromosomes 1 and 11, whereas individuals with the
milder phenotype II have inherited either the haplotype
of chromosome 1 or the haplotype of chromosome 11.
Individual III:1 has not been included in the analysis,
because of an atypical phenotype and because his in-
married father had hearing impairment. However, this
individual also carried the two haplotypes linked to the
disease. Finally, the unaffected persons who are 130
years of age have not inherited any of the disease hap-
lotypes. However, the haplotypes linked to the disease
were detected in two young unaffected individuals
(III:12 and III:5). First, individual III:12 received only
the haplotype on chromosome 1. He is 24 years old,
and he still has not passed the critical age at onset for
the milder form of hearing loss. Individual III:5, who is
14 years old, seems to have inherited both of the disease-
linked haplotypes from her affected father. However,
markers in the region between D1S201 and D1S255
were not informative. If she carries the two haplotypes,
then she already should have presented symptoms of
hearing loss, according to our model. Reduced pene-
trance or a double recombination event may explain the
absence of symptoms.
There have been several reports indicating a digenic
inheritance pattern in humans. For example, digenic seg-
regation has been demonstrated in families with retinitis
pigmentosa, in which the affected phenotype was caused
by mutations in two independent genes, peripherin/RDS
and ROM1 (Kajiwara et al. 1994) on 6p and 11q, re-
spectively. Electroretinograms of individuals heterozy-
gous for either mutation were very similar, although clin-
ical symptoms appeared only in double heterozygotes.
Digenic inheritance also was suggested for a family seg-
regating for Waardenburg syndrome type 2 with ocular
albinism. In this case, affected persons were heterozy-
gous for a mutation in a transcription factor and were
heterozygous or homozygous for a functionally signifi-
cant polymorphism of a tyrosinase gene (Morell et al.
1997). Aggravated hyperchlolesterolemia is caused by
nonallelic heterozygous mutations in two independent
loci implicated in the etiology of monogenic lipid dis-
orders—namely, the LDL receptor and the apolipopro-
tein B-100 locus, which encodes the ligand for the LDL
receptor (Benlian et al. 1996). Digenic inheritance also
has been postulated for families with limb-girdle mus-
cular dystrophy (LGMD) (Richard et al. 1995; van Om-
men 1995; Beckmann 1996), LGMD and Miyoshi my-
opathy (Weiler et al. 1996), recessive NSHL (Chen et al.
1997), and myelomeningocele and Waardenburg syn-
drome type 3 (Nye et al. 1998).
Although our results suggest that two loci segregate
with the more severe form of the disease, it is possible
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Figure 3 Comparison of the candidate regions for DFNA2 and DFNA12 on chromosomes 1p and 11q, respectively. Schematic repre-
sentations of chromosomes for key recombinants identified by other studies are illustrated to the left of the markers. Schematic representations
of chromosomes for key recombinants obtained in this study are illustrated to the right of the markers. Blackened bars indicate regions linked
to the disease allele, unblackened bars indicate regions that recombined with the disease allele, and boldface vertical lines indicate consensus
regions based on the combined information from the key recombinants. The numbers above the bars indicate the number of chromosomes for
each type of recombination. Arrows indicate possible locations for marker D1S472 on chromosome 1 and for marker D11S4171 on chromosome
11. For comparison purposes, the order of the markers on chromosome 1 was taken from the study by Van Camp et al. (1997a). Therefore,
the position of MYCL1 does not agree with the position according to the LDB, which we used for haplotype assignment and multipoint analysis.
that only one locus causes the hearing loss, while the
other segregates by chance. If this is the case, then the
locus on chromosome 11 is a stronger candidate than
the locus on chromosome 1, because the chromosome
11 locus is within a 12-cM region included within the
previously reported DFNA12 locus and because the sta-
tistical evidence is stronger (LOD score 13) for this locus
than for the chromosome 1 locus. If this is the case,
individual III:9 could be a phenocopy. On the other
hand, stronger statistical evidence for chromosome 11
was obtained only because the age at onset for the dis-
ease linked to this locus was assumed to be lower, and,
thus, more unaffected individuals were included in the
linkage analysis.
Another possible interpretation for the presence of
two phenotypic classes in the Swedish family might be
that the milder phenotype II is caused by a defective
nuclear gene and a mitochondrial mutation. This is sup-
ported by the observation that all four individuals with
phenotype II are offspring of affected mothers. However,
the absence of other clinical manifestations, such as di-
abetes or other neurological symptoms that usually co-
occur with hearing loss due to a mitochondrial mutation
(Jacobs 1997), as well as a negative history of treatment
with aminoglycosides (Estivill et al. 1998), do not sup-
port a mitochondrial etiology.
Comparisons of the results from our study with results
from previous studies of DFNA2 and DFNA12 are
shown in figure 3. The original work on DFNA2
(Coucke et al. 1994) described a region of 6 cM that
overlaps with our locus. This work was followed by
another study (Van Camp et al. 1997a) investigating new
families linked to DFNA2. In total, five families (one
from Indonesia, one from the United States, one from
Belgium, and two from The Netherlands) with similar
phenotypes linked to DFNA2 now have been analyzed.
The age at onset of the disease and the shape of audi-
ograms varied substantially between and within the fam-
ilies. The combination of data from all these families
defined a candidate region of !1.25 Mb for the disease
gene, flanked by markers D1S432 and MYCL1. In our
family, a recombination event between markersMYCL1
and D1S432 in affected person II:11 excluded the 1.25-
Mb region. The differences between the localization of
DFNA2 by Van Camp et al. (1997a) and by us may have
different explanations. In the Swedish family, the chro-
mosome 1 haplotype may segregate with the disease phe-
notype just by chance, as indicated above. Another pos-
sibility is that a second gene located on the same
chromosome might be implicated in the hearing loss. A
third possibility is the presence of other sequence ele-
ments, involved in transcriptional regulation of the
DFNA2 gene, that are located upstream of the DFNA2
locus, as has been suggested for the DFN3 locus (de Kok
et al. 1996). A final possibility is that there might be
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heterogeneity among the families described by Van
Camp et al. (1997a).
Another source of disagreement between the studies
is the order of the markers used. According to themarker
order from the LDB, MYCL1 is telomeric to D1S432,
whereas the opposite order is postulated by Van Camp
et al. (1997a). In their study, the order of the markers
was determined by recombination analysis of the indi-
viduals in the families studied. The finding that one in-
dividual was recombinant for marker MYCL1 indicated
that the disease gene was telomeric to MYCL1. Fur-
thermore, five recombinations were identified formarker
D1S432, which placed the disease gene centromeric to
this marker (fig. 3). As a result, these six recombinations
confined the region to markers MYCL1 and D1S432.
However, if marker MYCL1 resides telomeric to
D1S432 (as indicated in the LBD), then the linked region
would comprise two nonoverlapping regions, one that
is centromeric to marker D1S432 and another that is
telomeric to marker MYCL1. The latter region would
be a candidate in at least one of their families and would
coincide with the data from our family.
The linkage to locus DFNA12 is easier to analyze.
Congenital and stable hearing loss previously have been
shown to be linked to the 36-cM DFNA12 region re-
stricted bymarkers D11S4120 andD11S912 (Verhoeven
et al. 1997). Hearing loss in our family is linked to a
12-cM interval between markers D11S4104 and
D11S934, which is included within the 36-cM region.
Interestingly, the phenotype in our family is different
from that described by Verhoeven et al. (1997) (i.e., it
is progressive, with a later onset), which may indicate
allelic forms of hearing impairment at DFNA12 that are
analogous to other DFN loci (Liu et al. 1997a, 1997b;
Weil et al. 1997).
In summary, we have reported a family with pro-
gressive bilateral sensorineural NSHL with indications
of linkage to two independent loci, DFNA12 and
DFNA2. Our combined results from the analysis of hap-
lotypes and phenotypes support digenic inheritance of
the severe form of hearing loss observed in the family.
An additive effect of two independently segregating
genes is postulated, in which the contribution of each
gene results in a milder or subclinical phenotype.
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